Metoclopramide Injection, Solution
Product Images NDC 51662-1367

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Metoclopramide (NDC 51662-1367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

Metoclopramide is a drug used to treat gastrointestinal disorders but can cause a serious and irreversible movement disorder called tardive dyskinesia. Patients who experience signs or symptoms of tardive dyskinesia should discontinue treatment with metoclopramide as there is no known cure for the disorder. Prolonged treatment with metoclopramide can increase the risk of tardive dyskinesia, and the drug should be avoided for longer than 12 weeks except in rare cases where it is considered necessary. This information is a warning and should be read thoroughly before starting treatment with metoclopramide.*

FDA Label Image

Clinical Pharma 1 (Clinical Pharma 1)

This text provides pharmacokinetic parameters of a drug, including the volume of distribution (Vd), plasma protein binding, elimination half-life and oral bioavailability. Vd is 5 L/kg, with plasma protein binding around 30%. The elimination half-life is noted as 5 hours, and the oral bioavailability is reported as 80%+15.5%.*

FDA Label Image

Clinical Pharma 2 (Clinical Pharma 2)

FDA Label Image

How Supplied 1 (How Supplied 1)

This appears to be a label or instruction manual for a medical device. It contains information about different parts of the device, such as a plastic wrap that should not be removed, a syringe tip cap that can be removed, and an external collar that should not be removed. The purpose and function of the device cannot be determined from this text alone.*

FDA Label Image

How Supplied 2 (How Supplied 2)

FDA Label Image

How Supplied 3 (How Supplied 3)

FDA Label Image

Logo (Logo How Supplied)

FDA Label Image

Logo (Logo Medication Guide)

FDA Label Image

Structure (Structure)

FDA Label Image

Serialized Labeling (Serialized Syringe Labeling Blister Pack)

This appears to be a label or package insert for a medication or medical device. It includes information such as a product number, manufacturing information, and distribution details. It also advises the reader to refer to the manufacturer's package insert.*

FDA Label Image

Syringe Label 1 (Syringe Label 1)

NDC 76045-T07-20 is a prefilled single-use syringe that contains Metoclopramide Injection, USP. The injection is intended for IV or IM use and has a strength of 10 mg/2mL (Smg/mL). The medication should be stored at 20° to 25°C (68° to 77°F), protected from light, and retained in the carton until the time of use. The usual dosage can be found in the package insert, and any unused portion should be discarded. The syringe should not be placed on a sterile field. The validity date of this product has been removed. It is manufactured by Fresenius Kabi.*

FDA Label Image

Syringe Label 2 (Syringe Label 2)

This is a description for Metoclopramide 10 mg/2 mL Injection, USP for IV or IM use. The package is a Single-Use 2 mL container with 5 mg/mL Metoclopramide. The manufacturer is Fresenius Kabi and the product is available by prescription only. There are also some identification numbers on the package which may be relevant for tracking and tracing purposes.*

FDA Label Image

Syringe In Blister Pack (BACK)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.